Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.716
-0.014 (-1.85%)
At close: Jun 26, 2026, 4:00 PM EDT
0.710
-0.006 (-0.78%)
After-hours: Jun 26, 2026, 7:24 PM EDT
Longeveron Employees
Longeveron had 38 employees as of December 31, 2025. The number of employees increased by 12 or 46.15% compared to the previous year.
Employees
38
Change (1Y)
12
Growth (1Y)
46.15%
Revenue / Employee
$32,000
Profits / Employee
-$590,237
Market Cap
22.29M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Vistagen Therapeutics | 41 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
| Tvardi Therapeutics | 12 |
| VYNE Therapeutics | 10 |
| Neuphoria Therapeutics | 8 |
| Allarity Therapeutics | 8 |
LGVN News
- 10 days ago - New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer's Disease Accepted for Poster Presentation at the 2026 Alzheimer's Association International Conference (AAIC) - GlobeNewsWire
- 19 days ago - Longeveron granted SME status by European Medicines Agency - TheFly
- 19 days ago - Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA) - GlobeNewsWire
- 24 days ago - Longeveron to Present at BIO International Convention 2026 - GlobeNewsWire
- 5 weeks ago - Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities - GlobeNewsWire
- 5 weeks ago - Longeveron Proxy statement: Proxy filing - Filings
- 5 weeks ago - Longeveron Proxy statement: Proxy filing - Filings
- 6 weeks ago - Longeveron reports Q1 EPS (19c) vs. (34c) last year - TheFly